A Randomised Study of Conventional vs Low Dose Cyclosporine in Renal Transplant Recipients Treated With Cyclosporine, Mycophenolate Mofetil and Prednisone.

The benefits in terms of a reduction in the morbidity associated with acute organ allograft rejection indicate that mycophenolate mofetil should be considered as part of a primary therapy regimen in renal and cardiac transplant recipients, and as a treatment for reversal of acute refractory rejection in these patients. Further study is required to confirm its benefits in the transplantation of other solid organs.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A Randomised Study of Conventional vs Low Dose Cyclosporine in Renal Transplant Recipients Treated With Cyclosporine, Mycophenolate Mofetil and Prednisone.

Cited by 2 publications

References 0 publications

Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future

Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future

Mycophenolate Mofetil

Contact Info

Product

Resources

About